~ Buy the DAYVIGO (lemborexant) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR DAYVIGO

All Clinical Trials for DAYVIGO

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04555733 ↗	A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants	Completed	Eisai Co., Ltd.	Phase 1	2020-10-26	The primary objective of this study is to assess the pharmacokinetics (PK) of lemborexant and metabolites (M4, M9, and M10) in plasma in healthy Chinese participants following single and multiple oral doses of lemborexant.
NCT04818086 ↗	Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder	Recruiting	National Institute on Drug Abuse (NIDA)	Phase 1/Phase 2	2021-05-03	The purpose of this research study is to test the safety, tolerability, drug interactions with buprenorphine-naloxone, and effectiveness lemborexant when used to treat Opioid Use Disorder.
NCT04818086 ↗	Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder	Recruiting	Virginia Commonwealth University	Phase 1/Phase 2	2021-05-03	The purpose of this research study is to test the safety, tolerability, drug interactions with buprenorphine-naloxone, and effectiveness lemborexant when used to treat Opioid Use Disorder.
NCT04890561 ↗	A Study to Evaluate Lemborexant in Milk of Healthy Lactating Women	Completed	Eisai Inc.	Phase 1	2021-05-17	The primary purpose of the study is to estimate the cumulative amount of lemborexant excreted in breast milk following a single dose administration of lemborexant 10 milligram (mg) to healthy lactating women and to estimate the relative infant dose (RID) expressed as a percent of the daily maternal dose.

Clinical Trial Conditions for DAYVIGO

Condition Name

Condition Name for DAYVIGO
Intervention	Trials
Analgesics, Opioid	1
Drug Interaction	1
Healthy Volunteer	1
Healthy Volunteers	1

Condition MeSH

Condition MeSH for DAYVIGO
Intervention	Trials
Parasomnias	1
Dyssomnias	1
Opioid-Related Disorders	1
Alzheimer Disease	1

Clinical Trial Locations for DAYVIGO

Trials by Country

Trials by Country for DAYVIGO
Location	Trials
United States	5
China	1

Trials by US State

Trials by US State for DAYVIGO
Location	Trials
Missouri	1
Texas	1
California	1
Nevada	1
Virginia	1

Clinical Trial Progress for DAYVIGO

Clinical Trial Phase

Clinical Trial Phase for DAYVIGO
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2	2

Clinical Trial Status

Clinical Trial Status for DAYVIGO
Clinical Trial Phase	Trials
Not yet recruiting	3
Recruiting	2
Completed	2

Clinical Trial Sponsors for DAYVIGO

Sponsor Name

Sponsor Name for DAYVIGO
Sponsor	Trials
Eisai Inc.	2
Eisai Co., Ltd.	2
National Institute on Drug Abuse (NIDA)	1

Sponsor Type

Sponsor Type for DAYVIGO
Sponsor	Trials
Other	4
Industry	4
NIH	1